Skip to content Get your therapies funded, adopted and trusted — by proving value the whole health system believes.
Approval used to be the finish line. Now it’s barely the start. A therapy can clear the regulator, show strong clinical data, and still stall at the real wall: payers, HTA bodies and health systems deciding whether it’s worth funding — and at what price.
They’re asking harder questions than ever. Not just “does it work?” but “what does it do for outcomes, for system cost, for society?” — and all of it under intensifying scrutiny on affordability and public trust. Meanwhile access can’t be won by one function alone; it needs medical, commercial, regulatory, HEOR and external affairs pulling together, early.
This programme sharpens how you win that battle: building a value story the whole system believes, tailoring it to every stakeholder, and leading the cross-functional effort that gets your therapy to the patients who need it.
You work in or lead market access, HEOR, medical or commercial, and you’re accountable for getting therapies funded and adopted — not just approved. You want to think and lead more strategically across the whole access challenge.
Strengthens the organization’s ability to secure reimbursement, accelerate access, and demonstrate sustainable healthcare value — turning strong science into funded, adopted therapies.
You map the real journey from approval to funded adoption — the payer wall, HTA expectations, and the shift from product value to whole-system healthcare value that’s reshaping how therapies get paid for.
Clinical data alone won’t do it. You work on weaving clinical, health-economic and real-world evidence into one credible value narrative that answers the questions payers and HTA bodies are actually asking.
Payers, clinicians, procurement, policymakers and patient advocacy groups all want different things. You practise shaping the value story for each — same evidence, different narrative — so it lands with the people who decide.
Pricing is where value meets scrutiny. You explore outcomes-based and risk-sharing models, and how to balance innovation, patient access and affordability while protecting trust and reputation.
Access stalls in silos. You work on aligning medical, commercial, regulatory, HEOR and external affairs around a shared strategy, and engaging stakeholders early across the product lifecycle.
You leave with a concrete plan: the value story to build, the stakeholders to move, and the cross-functional alignment to make it happen.
Choose your learning format
Choose your preferred learning solution
Essentials of Project Management: For Non-Project Managers
Improving Your Project Management Skills
Project Management Excellence: The Complete Programme
